Clinical Trials Directory

Trials / Completed

CompletedNCT02998515

Effects of Different Oxygen Devices in Hypoxemic COPD Patients

Effects of Supplemental Oxygen Delivery Via Portable Oxygen Concentrator (Activox™4L) vs. Liquid Oxygen Device in Hypoxemic COPD Patients - a Non-inferiority Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Schön Klinik Berchtesgadener Land · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Taken recent literature together, there is a sufficient number of trials investigating the effect of different oxygen devices. However, studies comparing oxygen delivery via portable oxygen concentrator (POC) and liquid oxygen device (LOD) with appropriate exercise testing and sufficient power are missing. Given that walking is the most important activity of daily life to preserve the maintenance and to participate in social life, we aim to investigate the effects of two different oxygen delivery systems during walking in hypoxemic COPD patients (POC vs. LOD). The endurance shuttle walk test (ESWT) is well validated for measuring endurance walking capacity in COPD patients with good repeatability. The advantage of this test over the 6MWT is that the ESWT is performed at 85% of the individual maximum which is close to the intensity of typical daily activities. Due to the fact that the ESWT enables us to determine the maximum duration of exercise and to compare values at isotime (at the point of time when the shortest of the 3 ESWTs ends), we use the ESWT as exercise test in our trial.

Conditions

Interventions

TypeNameDescription
DEVICECompanion (Liquid oxygen device)
DEVICEActivox (concentrator)

Timeline

Start date
2016-12-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2016-12-20
Last updated
2017-08-21

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02998515. Inclusion in this directory is not an endorsement.